Entrada Therapeutics, Inc.

Rachunek Zysków i Strat





index 0 1 2 3 4 5
Rok finansowy 2019 2020 2021 2022 2023 2024
Przychód (mln) 0 0 0 0 129 211
Przychód Δ r/r 0.0% 0.0% 0.0% 0.0% inf% 63.4%
Marża brutto -inf% -inf% -inf% -inf% 97.8% 100.0%
EBIT (mln) -12 -27 -51 -97 -3 47
EBIT Δ r/r 0.0% 125.5% 91.7% 90.2% -96.7% -1586.7%
EBIT (%) 0.0% 0.0% 0.0% 0.0% -2.5% 22.3%
Koszty finansowe (mln) 0 0 -0 3 0 0
EBITDA (mln) -12 -26 -51 -97 -0 47
EBITDA(%) 0.0% 0.0% 0.0% 0.0% -0.2% 22.3%
Podatek (mln) -0 -0 -1 -7 19 1
Zysk Netto (mln) -5 -26 -50 -87 -7 66
Zysk netto Δ r/r 0.0% 467.4% 89.8% 74.7% -92.4% -1081.7%
Zysk netto (%) 0.0% 0.0% 0.0% 0.0% -5.2% 31.1%
EPS -0.15 -0.84 -1.6 -2.79 -0.2 1.76
EPS (rozwodnione) -0.15 -0.84 -1.6 -2.79 -0.2 1.68
Ilośc akcji (mln) 31 31 31 31 33 37
Ważona ilośc akcji (mln) 31 31 31 31 33 39
Waluta USD USD USD USD USD USD